A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
From designing pregnancy registries to getting all postmarketing trials done on time and under budget, this two-CD set, Postmarketing Clinical Trials, will help you maximize your investment, employ best practices, apply the best strategies and much more.
Postmarketing Clinical Trials Two-CD and Transcript Set